原发性肝癌的个体化综合治疗

蔡建强; 毕新宇

原发性肝癌的个体化综合治疗

中国医学科学院肿瘤医院腹部外科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 3418
- HTML全文浏览量: 14
- PDF下载量: 933
- 被引次数: 0
出版历程
- 收稿日期: 2011-02-11
- 出版日期: 2011-04-20

Individual and comprehensive therapy for primary liver cancer

摘要

摘要: 虽然近年来原发性肝癌的治疗取得了长足的进步,但是其总体疗效仍不令人满意。有机地结合目前各项治疗方式的优点,根据患者的个体情况制定合理的个体化综合治疗方案是患者获得长期生存的最佳手段。而规范的治疗方法、医生对疾病的认识及对临床证据的把握、患者对治疗的要求与期待、多学科综合治疗团队,是实施个体化综合治疗策略的4个最重要的因素。
- 肝肿瘤
Abstract: Although great progress has been made in the treatment of primary liver cancer, the overall survival is still far from satisfaction.To set up an individual and comprehensive protocol through an organic combination of different treatments and a considetation of the patient's situation, is the best way for the patients to get a favorable prognosis.Standardized treatment, doctor's professional knowledge on the disease and the best evidences, patient's intention, and multidisciplinary team are the key points to make a reasonable protocol.
- liver neoplasms

HTML全文

参考文献(9)

[1]Bosch FX, Ribes J, Diaz M, et al.Primary liver cancer:worldwide incidence and trends[J].Gastroenterology, 2004, 127 (Suppl 1) :s5-16.

[2]Williams R J.Biochemical individuality the Basis for theGenetotrophic Concept[M].New York:John Wiley&Sons, Inc, 1956:195.

[3]中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作专业委员会, 中华医学会肝病学分会肝癌学组.原发性肝癌规范化诊治的专家共识[J].临床肝胆病杂志, 2009, 25 (2) :83-92.

[4]Shimozawa N, Hanazaki K.Longterm prognosis after hepaticresection for small hepatocellular carcinoma[J].J Am CollSurg, 2004, 198 (3) :356-365.

[5]Zhou XD, Tang ZY, Ma ZC, et al.Surgery for large primaryliver cancer more than 10 cm in diameter[J].J Cancer ResClin Oncol, 2003, 129 (9) :543-548.

[6]Llovet JM, Fuster J, Bruix J.Intention-to-treat analysis ofsurgical treatment for early hepatocellular carcinoma:Resectionversus transplantation[J].Hepatology, 1999, 30 (6) :1434-1440.

[7]Figueras J, Ibanez L, Ramos E, et al.Selection criteria forliver transplantation in early stage hepatocellular carcinomawith cirrhosis:results of a multicenter study[J].Liver Transpl, 2001, 7 (10) :877-883.

[8]Lau WY, Leung TW, Yu SC, et al.Percutaneous local ablativetherapy for hepatocellular carcinoma:a review and look intothe future[J].Ann Surg, 2003, 237 (2) :171-179.

[9]Josep M, Llovet, Sergio Ricci, et al.Sorafenib in AdvancedHepatocellular Carcinoma[J].N ENGL J med, 2008:359 (4) :378-390.

施引文献

资源附件(0)

访问统计